Pulmonx (LUNG) Free Cash Flow (2019 - 2025)
Pulmonx (LUNG) reported Free Cash Flow of -$8.1 million for Q3 2025, up 2.84% year-over-year from -$7.9 million in Q3 2024, and down 121.26% on a QoQ basis from -$3.7 million in Q2 2025.
Pulmonx (LUNG) has 7 years of Free Cash Flow data on file, last reported at -$8.1 million in Q3 2025.
- Quarterly Free Cash Flow rose 2.84% year-over-year to -$8.1 million in Q3 2025, while the trailing twelve-month figure through Dec 2025 was -$25.3 million (up 20.31% YoY) and the FY2024 annual result came in at -$31.8 million, up 15.79% from the prior year.
- Free Cash Flow eased to -$8.1 million in Q3 2025 per LUNG's latest filing, from -$3.7 million in the prior quarter.
- Across five years, Free Cash Flow topped out at -$3.7 million in Q2 2025 and bottomed at -$15.6 million in Q1 2022.
- The 5-year median for Free Cash Flow is -$9.9 million (2022), against an average of -$9.8 million.
- The widest annual swing landed in 2021, when Free Cash Flow sank 69.56%; it then surged 33.52% in 2024.
- Tracing LUNG's Free Cash Flow over 5 years: stood at -$11.8 million in 2021, then rose by 23.29% to -$9.1 million in 2022, then climbed by 7.01% to -$8.5 million in 2023, then surged by 33.52% to -$5.6 million in 2024, then tumbled by 44.67% to -$8.1 million in 2025.
- Per Business Quant, the three latest LUNG Free Cash Flow figures stand at -$8.1 million (Q3 2025), -$3.7 million (Q2 2025), and -$13.5 million (Q1 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Free Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 916.00 Mn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 415.00 Mn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 2.30 Bn |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 171.00 Mn |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -21.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 305.56 Mn |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 449.00 Mn |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 204.00 Mn |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 245.20 Mn |
| 10 | Pulmonx | 67.30 Mn | -2.45 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | -8.13 Mn |
| Sep 30, 2025 | -8.13 Mn |
| Jun 30, 2025 | -3.67 Mn |
| Jun 30, 2025 | -3.67 Mn |
| Mar 31, 2025 | -13.50 Mn |
| Mar 31, 2025 | -13.50 Mn |
| Dec 31, 2024 | -5.62 Mn |
| Dec 31, 2024 | -5.62 Mn |
| Sep 30, 2024 | -8.37 Mn |
| Sep 30, 2024 | -8.37 Mn |
| Jun 30, 2024 | -5.52 Mn |
| Jun 30, 2024 | -5.52 Mn |
| Mar 31, 2024 | -12.25 Mn |
| Mar 31, 2024 | -12.25 Mn |
| Dec 31, 2023 | -8.45 Mn |
| Dec 31, 2023 | -8.45 Mn |
| Sep 30, 2023 | -8.64 Mn |
| Sep 30, 2023 | -8.64 Mn |
| Jun 30, 2023 | -7.55 Mn |
| Jun 30, 2023 | -7.55 Mn |
| Mar 31, 2023 | -13.07 Mn |
| Mar 31, 2023 | -13.07 Mn |
| Dec 31, 2022 | -9.09 Mn |
| Dec 31, 2022 | -9.09 Mn |
| Sep 30, 2022 | -10.97 Mn |
| Sep 30, 2022 | -10.97 Mn |
| Jun 30, 2022 | -9.86 Mn |
| Jun 30, 2022 | -9.86 Mn |
| Mar 31, 2022 | -15.59 Mn |
| Mar 31, 2022 | -15.59 Mn |
| Dec 31, 2021 | -11.85 Mn |
| Dec 31, 2021 | -11.85 Mn |
| Sep 30, 2021 | -10.22 Mn |
| Sep 30, 2021 | -10.22 Mn |
| Jun 30, 2021 | -13.07 Mn |
| Jun 30, 2021 | -13.07 Mn |
| Mar 31, 2021 | -9.94 Mn |
| Mar 31, 2021 | -9.94 Mn |
| Dec 31, 2020 | -7.04 Mn |
| Dec 31, 2020 | -7.04 Mn |
| Sep 30, 2020 | -6.14 Mn |
| Sep 30, 2020 | -6.14 Mn |
| Jun 30, 2020 | -7.71 Mn |
| Jun 30, 2020 | -7.71 Mn |
| Mar 31, 2020 | -9.82 Mn |
| Mar 31, 2020 | -9.82 Mn |
| Dec 31, 2019 | -3.69 Mn |
| Dec 31, 2019 | -3.69 Mn |